Clinical study of Landiolol hydrochloride in the treatment of postoperative atrial fibrillation/atrial flutter after cardiovascular surgery
Phase 4
- Conditions
- tachyarrhythmia
- Registration Number
- JPRN-UMIN000000957
- Lead Sponsor
- JL-Knight Study Group
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 400
Inclusion Criteria
Not provided
Exclusion Criteria
(1)acute myocardial infarction within 3 days (2)supraventricular arrhythmia (3)sick sinus syndrome (containing patients with pacemaker) (4)grave heart failure (preoperative NYHA Classification of the Stages of Heart Failure, more than or equal to third degree) (5)atrioventricular block, more than or equal to second degree (6)contraindication to beta-blockers or , calcium channel blockers (7)electrolyte imbalance, WPW syndrome or hyperthyroidism (8)blood pressure < 90/60 mmHg (9)postoperative peroral use of beta-blockers or, calcium channel blockers (10)use of operative and postoperative antiarrhythmic medications excluding Digitalis
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method